Table 2.
Clinical characteristics of enrolled subjects with confirmed ASB and sterile urine (N = 248)*
| Clinical characteristics | Confirmed ASB N = 14 | Sterile urine N = 234 |
| Age yr | 27.9 ± 2.3 | 26.4 ± 2.5 |
| †Gender (M:F) | 1:13 | 124:110 |
| #Genotype frequency (HbSS:HbSC:HbSβ0:HbSβ+: sickle variants) | 9:2:1:2:0 | 130:75:5:19:5 |
| Creatinine μmol/L | 49.1 ± 12.4 | 53.7 ± 14.3 |
| Uric Acid mmol/L | 0.36 ± 0.29 | 0.33 ± 0.08 |
| †Proteinuria ≥ trace : No proteinuria (n = 168) | 1:7 | 22 :138 |
| †Positive History of gram negative sepsis | 1 | 1 |
| †Positive recorded history of ever having UTI | 7 | 25 |
| †Cumulative number of recorded clinic visits for symptomatic UTI* | 18 | 49 |
*Values of subjects with probable ASB excluded from table. † Values are counts. Abbreviations : ASB = asymptomatic bacteriuria; HbSC= Sickle cell-haemoglobin C, HbSβ0 = Sickle cell-β0 thalassemia, HbSβ+ = Sickle cell-β+ thalassemia; UTI = Urinary Tract Infections
#Sickle variants include sickle cell-hereditary persistence of foetal haemoglobin, sickle cell -haemoglobin O Arab, sickle cell -haemoglobin Lepore-Boston;